Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Lundberg Theodore B.	2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) C/O ADAPTHEALTH CORP., 220 W. GERMANTOWN PIKE, SUITE 250	3. Date of Earliest Transaction (MM/DD/YYYY) 8/23/2021
(Street) PLYMOUTH MEETING, PA 19462 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	8/23/2021		A		4509 (1)	A	$0	4509	D
Common Stock								6680833	I	See footnote (2)
Common Stock								634347	I	See footnote (3)
Common Stock								2142163	I	See footnote (4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:
(1)	Represents a grant of restricted stock to the Reporting Person, a director of the Issuer. The proceeds of any sale of these shares will be transferred to Peloton Equity, LLC and as such, the Reporting Person disclaims ownership of such shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
(2)	Shares held by Peloton AeroCare SPV I, L.P. ("Peloton AeroCare I"). Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton AeroCare I except to the extent of his pecuniary interest therein, if any. Includes 3,214,007 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.
(3)	Shares held by Peloton AeroCare SPV II, L.P. ("Peloton AeroCare II"). Peloton Equity GP is the general partner of Peloton AeroCare II. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton AeroCare II except to the extent of his pecuniary interest therein, if any. Includes 306,087 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.
(4)	Shares held by Peloton Equity I, L.P. ("Peloton Equity I"). Peloton Equity GP is the general partner of Peloton Equity I. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton Equity I except to the extent of his pecuniary interest therein, if any. Includes 1,033,644 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Lundberg Theodore B. C/O ADAPTHEALTH CORP. 220 W. GERMANTOWN PIKE, SUITE 250 PLYMOUTH MEETING, PA 19462	X

Signatures
/s/ Theodore B. Lundberg***		8/25/2021
**Signature of Reporting Person		Date